Byrd JC, Hillmen P, Ghia P, Kater AP, et al. Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial. J Clin Oncol 2021 Jul 26:JCO2101210. doi: 10.1200/JCO.21.01210.
PMID: 34310172